Product Specification
Alternative Name: | Lysyl oxidase-like protein 4 |
|
Host: | Rabbit |
|
Immunogen: | Synthetic peptide corresponding to the second of four N-terminal scavenger receptor cysteine rich (SRCR) domains of human LOXL4. |
|
UniProt ID: | Q96JB6 |
|
Species reactivity: | Human
|
|
Applications: | Flow Cytometry, ICC, IHC, WB
|
|
Recommended Dilutions/Conditions: | Immunocytochemistry (1:600-1:800) Immunohistochemistry (paraffin sections, 1:500) Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
|
Formulation: | Liquid. Neat serum. Contains no preservatives. |
|
Handling: | Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C. |
|
Shipping: | Shipped on Blue Ice |
|
Long Term Storage: | -20°C |
|
Regulatory Status: | RUO - Research Use Only |
|
Product Literature References
Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia: X.H. Xu, et al.; Exp. Mol. Med.
51, 20 (2019),
Abstract;
Full Text
LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer: J.B. Weise, et al.; Eur. J. Cancer
44, 1323 (2008),
Abstract;
Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma: T. Görögh, et al.; J. Pathol.
212, 74 (2007),
Abstract;